Mckesson Medical-Surgical Inc. Corporate Office recalls Medroxyprogesterone Acetate Injectable Suspension
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
- Products
-
- Medroxyprogesterone Acetate Injectable Suspension
- Where it was sold
-
Distributed to Medical Facilities in MS and FL.
States: Florida, Mississippi
- Units affected
- 3
- About this recall
- Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01